News & Articles
Selected Filters:
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
Siemens collaborates with CDC to develop a novel process for standardizing SARS-CoV-2 assays
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
FDA clears AI-based MRI interpretation assistants from Siemens Healthineers
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
FDA clears Siemens Healthineers' bedside computed tomography scanner
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
Siemens Healthineers obtains first FDA EUA for semi-quantitative antibody test
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
Siemens Healthineers and Geisinger announce value partnership to drive digital healthcare
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Siemens Healthineers receives FDA emergency use authorization for SARS-CoV-2 total antibody test
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
Siemens Healthineers now shipping worldwide total antibody test and molecular test kit for COVID-19
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
Siemens Healthineers begins delivery of CE-IVD registered SARS-CoV-2 test kits
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
Siemens Healthineers to expand COVID-19 testing to include antibody test
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio
Siemens Healthineers receives FDA clearance to support COVID-19 response efforts
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
Siemens Healthineers adds fentanyl assay to its portfolio
New assay is designed to help laboratories address greater demand for opioid testing
AI-based assistants for magnetic resonance imaging
Discover Revolutionary Sample Management Technology at AACC 2019
The Atellica Solution from Siemens Healthineers promises more control and increased simplicity in your lab workflows
Siemens Healthineers Introduces Innovative Heart Attack Diagnosis Test
The Siemens Healthineers High-Sensitivity Troponin I assays can detect lower levels of troponin compared to conventional assays
Early Adopters Say Atellica Solution Exceeds their Performance Expectations
World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance
Siemens Healthineers to Exhibit Atellica Solution at AACC 2018
Discover the Scientists' Choice Award nominee Atellica Solution at AACC July 29 - August 2, 2018
Sartorius Stedim Biotech and Siemens Sign Long Term Cooperation Agreement in the Area of Automation
Siemens becomes a preferred supplier for automation solutions
Siemens Healthineers Receives FDA Clearance for Blood Urea Nitrogen and Total CO<sub>2</sub> Point-of-Care Testing
Testing at the point-of-care improves patient care with results in less than a minute
Siemens Healthineers Announces Acquisition of Fast Track Diagnostics (FTD)
FTD's broad range of CE-marked infectious disease detection tests and syndromic panels expands the Siemens Healthineers molecular diagnostics portfolio